ROSSI, MARZIA
 Distribuzione geografica
Continente #
EU - Europa 400
NA - Nord America 341
AS - Asia 149
AF - Africa 8
Totale 898
Nazione #
US - Stati Uniti d'America 335
IT - Italia 179
CN - Cina 101
IE - Irlanda 82
SE - Svezia 74
SG - Singapore 24
DE - Germania 17
FI - Finlandia 12
FR - Francia 9
TR - Turchia 9
CI - Costa d'Avorio 8
CA - Canada 6
AT - Austria 4
CH - Svizzera 4
RO - Romania 4
BE - Belgio 3
ES - Italia 3
JP - Giappone 3
NL - Olanda 3
TH - Thailandia 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
PK - Pakistan 2
TW - Taiwan 2
EE - Estonia 1
GB - Regno Unito 1
HK - Hong Kong 1
IN - India 1
KR - Corea 1
RS - Serbia 1
UA - Ucraina 1
Totale 898
Città #
Dublin 82
Chandler 70
Parma 45
Ann Arbor 37
Shanghai 36
New York 31
Ashburn 23
Beijing 23
Milan 23
Dearborn 18
Chicago 17
Bologna 13
Wilmington 10
Guangzhou 9
Limena 9
Princeton 9
Abidjan 8
Singapore 8
Boardman 7
Helsinki 7
Houston 7
Izmir 7
Bremen 6
Toronto 6
Reggio Emilia 5
Ardea 4
Falls Church 4
Focsani 4
Lausanne 4
Nanjing 4
Piacenza 4
Rome 4
Sant'ilario D'enza 4
Vienna 4
Bangkok 3
Brussels 3
Cortemaggiore 3
Fairfield 3
Grafing 3
Los Angeles 3
Modena 3
Nepi 3
Santa Margherita Ligure 3
Shenyang 3
Des Moines 2
Haikou 2
Hangzhou 2
Hefei 2
Kocaeli 2
Kunming 2
Mirandola 2
Montespertoli 2
San Mateo 2
Santa Ana 2
Seattle 2
Segrate 2
Sesto Fiorentino 2
Taipei 2
Terni 2
Tokyo 2
Uithoorn 2
Zaragoza 2
Zhengzhou 2
Barcelona 1
Bomporto 1
Borås 1
Brno 1
Campogalliano 1
Carpi 1
Catania 1
Cento 1
Central 1
Changsha 1
Cremona 1
Cuttack 1
Dhaka 1
Fremont 1
Gunzenhausen 1
Hebei 1
Jiaxing 1
Leawood 1
London 1
Nakano 1
Naples 1
Norwalk 1
Novi Sad 1
Nuremberg 1
Old Bridge 1
Pavia 1
Podenzano 1
Prineville 1
Quattro Castella 1
Redwood City 1
Rockville 1
San Jose 1
Scandiano 1
Soliera 1
Suello 1
Taiyuan 1
Tallinn 1
Totale 657
Nome #
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 125
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 87
Metabolic regulation of the HBV-specific T cell function 78
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 74
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 70
T cell regulation in HBV-related chronic liver disease 62
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 54
HBV immune-therapy: From molecular mechanisms to clinical applications 54
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 50
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 48
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 47
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 44
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 38
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 30
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 29
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 17
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 16
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 12
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 5
Totale 940
Categoria #
all - tutte 4.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.207


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202075 10 7 1 1 3 22 10 5 7 0 9 0
2020/202195 2 3 0 1 11 15 18 9 11 8 5 12
2021/202292 8 3 3 17 9 6 9 4 5 2 6 20
2022/2023316 33 30 17 14 33 27 7 12 90 1 16 36
2023/2024311 22 36 22 30 12 45 32 18 13 20 23 38
2024/202515 15 0 0 0 0 0 0 0 0 0 0 0
Totale 940